Astellas Pharma (4503.T) Revenue
Market Cap: $2.57T
Avg Volume: 6.89M
Industry: Drug Manufacturers - General
Sector: Healthcare
What is Astellas Pharma's Revenue?
Astellas Pharma's quarterly revenue as of Q3 2024 is $517.41B.
Astellas Pharma's annual revenue for the fiscal year 2023 is $1.60T.
Related metrics for Astellas Pharma (quarterly):
- Cost of Revenue: $98.52B
- Gross Profit: $418.88B
- Gross Profit Ratio: 80.96%
- Revenue Per Share: $289.09
- Revenue Growth: 11.87%
Apple's quarterly revenue was $517.41B, with a cost of revenue of $98.52B, which leaves $418.88B gross profit and a gross profit ratio of 80.96%.
Related metrics for Astellas Pharma (annual):
- Cost of Revenue: $292.49B
- Gross Profit: $1.31T
- Gross Profit Ratio: 81.76%
- Revenue Per Share: $894.27
- Revenue Growth: 5.60%
Apple's annual revenue was $1.60T, with a cost of revenue of $292.49B, which leaves $1.31T gross profit and a gross profit ratio of 81.76%.
Understanding Revenue
Revenue is the total amount of income generated by the sale of goods or services related to the company's primary operations. It is often referred to as the "top line" because it sits at the top of the income statement.
End of Year Revenue
The table below shows the revenue for each fiscal year, with the latest data available for 2023.
| Year | Revenue | Change |
|---|---|---|
| 2023 | $1.60T | 5.60% |
| 2022 | $1.52T | 17.16% |
| 2021 | $1.30T | 3.73% |
| 2020 | $1.25T | -3.94% |
| 2019 | $1.30T | -0.42% |
| 2018 | $1.31T | 0.46% |
| 2017 | $1.30T | -0.87% |
| 2016 | $1.31T | -4.45% |
| 2015 | $1.37T | 10.06% |
| 2014 | $1.25T | 9.42% |
| 2013 | $1.14T | 13.35% |
| 2012 | $1.01T | 3.74% |
| 2011 | $969.39B | 1.62% |
| 2010 | $953.95B | -2.15% |
| 2009 | $974.88B | 0.95% |
| 2008 | $965.70B | -0.71% |
| 2007 | $972.59B | 5.64% |
| 2006 | $920.62B | 4.69% |
| 2005 | $879.36B | 96.70% |
| 2004 | $447.05B | -12.55% |
| 2003 | $511.21B | N/A |
Related Metrics
Explore detailed financial metrics and analysis for 4503.T.